<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22205956</article-id><article-id pub-id-type="pmc">3243682</article-id><article-id pub-id-type="publisher-id">PONE-D-11-12844</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0028608</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Population Biology</subject><subj-group><subject>Epidemiology</subject><subject>Population Dynamics</subject></subj-group></subj-group><subj-group><subject>Theoretical Biology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Mathematics</subject><subj-group><subject>Nonlinear Dynamics</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Global Health</subject></subj-group><subj-group><subject>Infectious diseases</subject><subj-group><subject>Viral diseases</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV epidemiology</subject><subject>HIV prevention</subject></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Obstetrics and Gynecology</subject><subj-group><subject>Genitourinary Infections</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group><subj-group><subject>Public Health</subject><subj-group><subject>Disease Ecology</subject><subject>Preventive Medicine</subject></subj-group></subj-group><subj-group><subject>Urology</subject><subj-group><subject>Genitourinary Infections</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Modeling the Population-Level Effects of Male Circumcision as an HIV-Preventive Measure: A Gendered Perspective</article-title><alt-title alt-title-type="running-head">Male Circumcision, HIV Transmission and Gender</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dushoff</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1">
<sup>&#x0002a;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Patocs</surname><given-names>Audrey</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Shi</surname><given-names>Chyun-Fung</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">
<addr-line>Department of Biology and Institute of Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Colizza</surname><given-names>Vittoria</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">INSERM and Universite Pierre et Marie Curie, France</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>dushoff@mcmaster.ca</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: JD AP. Performed the experiments: JD AP. Analyzed the data: JD AP C-FS. Contributed reagents/materials/analysis tools: JD. Wrote the paper: JD AP C-FS.</p></fn></author-notes><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>20</day><month>12</month><year>2011</year></pub-date><volume>6</volume><issue>12</issue><elocation-id>e28608</elocation-id><history><date date-type="received"><day>5</day><month>7</month><year>2011</year></date><date date-type="accepted"><day>11</day><month>11</month><year>2011</year></date></history><permissions><copyright-statement>Dushoff et al.</copyright-statement><copyright-year>2011</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Evidence from biological, epidemiological, and controlled intervention studies has demonstrated that male circumcision (MC) protects males from HIV infection, and MC is now advocated as a public-health intervention against HIV. MC provides <italic>direct</italic> protection only to men, but is expected to provide <italic>indirect</italic> protection to women at risk of acquiring HIV from heterosexual transmission. How such indirect protection interacts with the possibility that MC campaigns will lead to behavior changes, however, is not yet well understood. Our objective here is to investigate the link between <italic>individual-level</italic> effects of MC campaigns and long-term <italic>population-level</italic> outcomes resulting from disease dynamics, looking at both genders separately, over a broad range of parameters.</p></sec><sec><title>Methods and Findings</title><p>We use simple mathematical models of heterosexual transmission to investigate the potential effects of a circumcision scale-up, combined with possible associated behavioral disinhibition. We examine patterns in expected long-term prevalence using a simple equilibrium model based on transmission factors, and validate our results with ODE-based simulations, focusing on the link between effects on females and those on males.We find that the long-term population-level effects on females and males are not strongly linked: there are many possible ways in which an intervention which reduces prevalence in males might nonetheless increase prevalence in females.</p></sec><sec><title>Conclusions</title><p>Since an intervention that reduces long-term male prevalence could nonetheless increase long-term female prevalence, MC campaigns should explicitly consider both the short-term and long-term effects of MC interventions on females. Our findings strongly underline the importance of pairing MC programs with education, support programs and HIV testing and counseling, together with other prevention measures.</p></sec></abstract><counts><page-count count="7"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>The HIV epidemic continues to exact a high toll, with 2.6 million new infections, and 1.8 million deaths, in 2009 <xref rid="pone.0028608-Joint1" ref-type="bibr">[1]</xref>. Despite being home to only 10&#x00025; of the world's population, Sub-Saharan Africa (SSA) represents two thirds of all persons living with HIV/AIDS, most of whom do not have access to anti-retroviral treatments <xref rid="pone.0028608-Joint1" ref-type="bibr">[1]</xref>. Research into preventative vaccines, pre-exposure prophylaxis <xref rid="pone.0028608-Grant1" ref-type="bibr">[2]</xref> and topical microbicides has yet to deliver an efficacious tool for preventing HIV transmission <xref rid="pone.0028608-Kort1" ref-type="bibr">[3]</xref>, <xref rid="pone.0028608-Padian1" ref-type="bibr">[4]</xref>. Current efforts to halt HIV transmission are focused largely around education and voluntary counseling and testing (VCT), antiretroviral prophylaxis to prevent mother-to-child transmission, treatment for prevention <xref rid="pone.0028608-Cohen1" ref-type="bibr">[5]</xref>, and recently, male circumcision (MC) campaigns <xref rid="pone.0028608-Siegfried1" ref-type="bibr">[6]</xref>, <xref rid="pone.0028608-World1" ref-type="bibr">[7]</xref>.</p><p>Evidence that MC provides partial protection to men against acquiring HIV infection from women has been accumulating for over 20 years <xref rid="pone.0028608-Siegfried1" ref-type="bibr">[6]</xref>. Following randomized controlled trials (RCTs) in South Africa <xref rid="pone.0028608-Auvert1" ref-type="bibr">[8]</xref>, Kenya <xref rid="pone.0028608-Bailey1" ref-type="bibr">[9]</xref>, and Uganda <xref rid="pone.0028608-Gray1" ref-type="bibr">[10]</xref> that demonstrated clinical efficacy of MC in preventing HIV transmission, the World Health Organization (WHO) recommended that promoting male circumcision be adopted as an anti-HIV strategy, while adding caveats about providing information, considering women's perspectives, and communicating fully and clearly, among others <xref rid="pone.0028608-World1" ref-type="bibr">[7]</xref>. While MC holds promise to boost existing anti-HIV strategies, it also poses a complex set of issues because it provides only limited protection. In particular, it is important to guard against the danger of disinhibition &#x02013; ie., that circumcised men will engage in riskier behavior, or that women will be more willing to engage in risky behavior with circumcised men <xref rid="pone.0028608-Kalichman1" ref-type="bibr">[11]</xref>.</p><p>Behavioural disinhibition is a pervasive feature of human behavior <xref rid="pone.0028608-Cassell1" ref-type="bibr">[12]</xref> and should be considered as a possible reaction to any protective intervention. Behavioural disinhibition has been documented in HIV microbicide trials <xref rid="pone.0028608-Jackson1" ref-type="bibr">[13]</xref>, following anti-retroviral treatment rollout <xref rid="pone.0028608-Crepaz1" ref-type="bibr">[14]</xref>, and following negative HIV tests <xref rid="pone.0028608-Sherr1" ref-type="bibr">[15]</xref>.There are as yet no studies of behavioral disinhibition in the context of population-scale MC interventions. Analysis of national population-based surveys in SSA showed that circumcised men are more likely to have concurrent partners than uncircumcised males <xref rid="pone.0028608-Vinod1" ref-type="bibr">[16]</xref>, but these are ecological data, and do not specifically focus on interventions. A prospective, case-control study in Kenya compared men who chose to be circumcised with matched controls, and found no differences in risk behaviors at one year post-circumcision <xref rid="pone.0028608-Agot1" ref-type="bibr">[17]</xref>. Although some indications of behavioral disinhibition were seen in the MC-intervention RCTs <xref rid="pone.0028608-Auvert1" ref-type="bibr">[8]</xref>&#x02013;<xref rid="pone.0028608-Gray1" ref-type="bibr">[10]</xref>, these were not strong (and mostly not statistically significant). RCTs tend to focus on education, however, which can reduce risky behavior <xref rid="pone.0028608-Matovu1" ref-type="bibr">[18]</xref>, and may therefore tend to suppress disinhibition.There is also the possibility that promotion of circumcision in mass circumcision campaigns will contribute to beliefs which increase disinhibition. Such beliefs are already present; for example a 2011 study of MC and disinhibition in three southern African countries found that a large proportion of respondents believed that circumcision was more protective than it is <xref rid="pone.0028608-Andersson1" ref-type="bibr">[19]</xref>. Thus, disinhibition should be considered a potential risk as MC campaigns go forward.</p><p>Studies of MC have mostly focused on effects on men. This is sensible, because MC directly protects men from infection, and &#x02013; since women acquire HIV infection primarily from heterosexual transmission &#x02013; direct protection for men translates to a certain amount of indirect protection for women. The possibility of behavioral disinhibition complicates this picture. Since there is no evidence for direct protection of women <xref rid="pone.0028608-Wawer1" ref-type="bibr">[20]</xref>, <xref rid="pone.0028608-Weiss1" ref-type="bibr">[21]</xref>, it is useful to ask whether an MC intervention that stimulates behavioral disinhibition could under some circumstances increase incidence in women while reducing incidence in men.</p><p>Women are disproportionately vulnerable to HIV infection in Africa, as evidenced by female prevalence rates that exceed male rates in nearly every country in SSA <xref rid="pone.0028608-Joint2" ref-type="bibr">[22]</xref>. While this trend may be partially driven by biological factors, unbalanced gender-power relationships and violence against women also play important roles <xref rid="pone.0028608-Jewkes1" ref-type="bibr">[23]</xref>. Many more male than female respondents in SSA population surveys report multiple sexual partners in the previous year, and many females do not believe they have the right to refuse sex to partners <xref rid="pone.0028608-Andersson2" ref-type="bibr">[24]</xref>. These social factors contribute to a situation where male beliefs and behaviors have a large influence on female HIV risk.</p><p>A wide range of mathematical models have predicted reductions in HIV prevalence following large-scale MC <xref rid="pone.0028608-Group1" ref-type="bibr">[25]</xref>, including two that acknowledged the possibility that female prevalence could go up even as male prevalence goes down in the presence of behavioral disinhibition <xref rid="pone.0028608-Alsallaq1" ref-type="bibr">[26]</xref>, <xref rid="pone.0028608-Hallett1" ref-type="bibr">[27]</xref>. We are not aware, however, of studies that systematically explore how closely linked we should expect effects on males and females to be.</p><p>Here, we use a simple equilibrium analysis, based on &#x0201c;transmission factors&#x0201d; <xref rid="pone.0028608-Bailey2" ref-type="bibr">[28]</xref>, and taking individual-level heterogeneity in sexual mixing into account (using the approach of <xref rid="pone.0028608-Granich1" ref-type="bibr">[29]</xref>). Transmission factors are analogous to the basic reproductive number, but instead ask how many cases will an average case <italic>in a given gender</italic> produce in a susceptible population <italic>of the other gender</italic>.The expected relationship between transmission factors and the predicted equilibrium prevalence in each gender is robust to assumptions about details of transmission and progression, including contact rates, probability of transmission and duration of latency and infectiousness.</p><p>Thus, the transmission factor approach allows us to explore the balance between protection and disinhibition in women and men over a wide range of parameters, and ask how broad are the parameters under which effects on men and effects on women move in different directions &#x02013; ie., how safe is the assumption that an MC intervention with net benefits for men will also have net benefits for women?</p><p>Transmission factors are products of risk factors such as contact rates, duration of infectiousness and transmission probabilities. In this model, the effect of different mechanisms of protection and disinhibition on predicted equilibria depends only on how they affect the two transmission factors. We validate our conclusions from the equilibrium analysis using more detailed simulation models, which show very similar qualitative behavior for the selected parameters. For simplicity in addressing the question of how closely linked two genders are in a heterosexually transmitted disease, we do not consider homosexual transmission, nor mother-to-child transmission.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Equilibrium calculations</title><p>The transmission factor approach <xref rid="pone.0028608-Bailey2" ref-type="bibr">[28]</xref> allows equilibrium prevalence in each gender to be estimated based on unitless transmission factors reflecting overall risk of transmission from each gender to the other. We incorporate a phenomenological response to prevalence as a proxy for heterogeneity <xref rid="pone.0028608-Granich1" ref-type="bibr">[29]</xref>. Thus, we solve two simultaneous equations of the form:<disp-formula><graphic xlink:href="pone.0028608.e001.jpg" mimetype="image" position="float"/><label>(1)</label></disp-formula>to obtain <inline-formula><inline-graphic xlink:href="pone.0028608.e002.jpg" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pone.0028608.e003.jpg" mimetype="image"/></inline-formula>, the proportion of sexually active females and males respectively &#x0201c;affected&#x0201d; by the disease if it reaches equilibrium. <inline-formula><inline-graphic xlink:href="pone.0028608.e004.jpg" mimetype="image"/></inline-formula> is the &#x0201c;transmission factor&#x0201d; describing transmission <italic>from</italic> males <italic>to</italic> females. The equilibrium equation for the male population is exactly symmetric.</p><p>The parameter <inline-formula><inline-graphic xlink:href="pone.0028608.e005.jpg" mimetype="image"/></inline-formula> sets the strength of the heterogeneity response. If we set <inline-formula><inline-graphic xlink:href="pone.0028608.e006.jpg" mimetype="image"/></inline-formula>, we would have a classic homogeneous model. In a heterogeneous population, we expect effective transmission to be reduced as prevalence increases, largely because the average contact rate and susceptibility of those in the susceptible pool decrease as the most susceptible individuals move to the infected class <xref rid="pone.0028608-Granich1" ref-type="bibr">[29]</xref>, <xref rid="pone.0028608-Williams1" ref-type="bibr">[30]</xref>. To explore the effects of interventions and behavior changes on equilibrium prevalence, we hold the value of <inline-formula><inline-graphic xlink:href="pone.0028608.e007.jpg" mimetype="image"/></inline-formula> constant, and calculate equilibria over a wide range of values of the transmission factors, which incorporate the various risk behaviors that determine the average number of new potential infections that are generated by each infection. We obtained the value <inline-formula><inline-graphic xlink:href="pone.0028608.e008.jpg" mimetype="image"/></inline-formula> using crude (least-squares) fits to prevalence data from antenatal clinics in sub-Saharan Africa &#x02013; we use it here as a reasonable example, and not to suggest we have described the heterogeneity response in detail.</p></sec><sec id="s2b"><title>Dynamical simulations</title><p>Our dynamical model is diagrammed in <xref ref-type="fig" rid="pone-0028608-g001">Figure 1</xref>. We divide the sexually active population into females, uncircumcised males and circumcised males; each group can be either susceptible or infected. We further divide the infected classes into equivalent subclasses, to achieve a more realistic distribution of time to death <xref rid="pone.0028608-Granich1" ref-type="bibr">[29]</xref>. We model this dynamical system using a standard ODE approach.</p><fig id="pone-0028608-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0028608.g001</object-id><label>Figure 1</label><caption><title>Simplified model diagram.</title><p>Disease is transmitted among females, and circumcised and uncircumcised males (indexed by <inline-formula><inline-graphic xlink:href="pone.0028608.e009.jpg" mimetype="image"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pone.0028608.e010.jpg" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pone.0028608.e011.jpg" mimetype="image"/></inline-formula>. Susceptible individuals (<inline-formula><inline-graphic xlink:href="pone.0028608.e012.jpg" mimetype="image"/></inline-formula>) exposed to infection move to infectious classes <inline-formula><inline-graphic xlink:href="pone.0028608.e013.jpg" mimetype="image"/></inline-formula>). <inline-formula><inline-graphic xlink:href="pone.0028608.e014.jpg" mimetype="image"/></inline-formula> represents &#x0201c;births&#x0201d; (really, recruitment to sexual activity) in males and females respectively. <inline-formula><inline-graphic xlink:href="pone.0028608.e015.jpg" mimetype="image"/></inline-formula> is the rate at which males become circumcised; it is calculated to give the desired equilibrium proportion of circumcised susceptible males. The forces of infection are given by <inline-formula><inline-graphic xlink:href="pone.0028608.e016.jpg" mimetype="image"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pone.0028608.e017.jpg" mimetype="image"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pone.0028608.e018.jpg" mimetype="image"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pone.0028608.e019.jpg" mimetype="image"/></inline-formula>, where <inline-formula><inline-graphic xlink:href="pone.0028608.e020.jpg" mimetype="image"/></inline-formula> is prevalence in each class, <inline-formula><inline-graphic xlink:href="pone.0028608.e021.jpg" mimetype="image"/></inline-formula>s are intrinsic transmission rates, and <inline-formula><inline-graphic xlink:href="pone.0028608.e022.jpg" mimetype="image"/></inline-formula> is the heterogeneity parameter. <inline-formula><inline-graphic xlink:href="pone.0028608.e023.jpg" mimetype="image"/></inline-formula> represents direct protection of circumcised males, and <inline-formula><inline-graphic xlink:href="pone.0028608.e024.jpg" mimetype="image"/></inline-formula> represents disinhibition. Our ODE model has four identical sub-boxes for each infectious box, to better match the time distribution of the infectious period <xref rid="pone.0028608-Granich1" ref-type="bibr">[29]</xref>.</p></caption><graphic xlink:href="pone.0028608.g001"/></fig><p>The model parameters are given in <xref ref-type="table" rid="pone-0028608-t001">Table 1</xref>. They are broadly consistent with what is known about HIV transmission in southern Africa, and with other recent transmission models <xref rid="pone.0028608-Granich1" ref-type="bibr">[29]</xref>&#x02013;<xref rid="pone.0028608-Podder1" ref-type="bibr">[31]</xref>. Males and females enter the susceptible (sexually active) population at a constant rate, and become infected at a rate proportional to the proportion of heterosexual partners infected and the transmission risk associated with a given sexual encounter.</p><table-wrap id="pone-0028608-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0028608.t001</object-id><label>Table 1</label><caption><title>Parameters used in simulations shown here.</title></caption><alternatives><graphic id="pone-0028608-t001-1" xlink:href="pone.0028608.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Parameter</td><td align="left" rowspan="1" colspan="1">Value</td><td align="left" rowspan="1" colspan="1">Source</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">HIV prevalence at MC implementation</td><td align="left" rowspan="1" colspan="1">25&#x00025;</td><td align="left" rowspan="1" colspan="1">Assumption<xref ref-type="table-fn" rid="nt101">&#x0002a;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Proportion circumcised at baseline</td><td align="left" rowspan="1" colspan="1">15&#x00025;</td><td align="left" rowspan="1" colspan="1">
<xref rid="pone.0028608-Joint3" ref-type="bibr">[38]</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Equilibrium proportion circumcised after intervention</td><td align="left" rowspan="1" colspan="1">80&#x00025;</td><td align="left" rowspan="1" colspan="1">Assumption<xref ref-type="table-fn" rid="nt101">&#x0002a;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Average time spent in susceptible class</td><td align="left" rowspan="1" colspan="1">40 yrs</td><td align="left" rowspan="1" colspan="1">
<xref rid="pone.0028608-World2" ref-type="bibr">[39]</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Reproductive number <inline-formula><inline-graphic xlink:href="pone.0028608.e025.jpg" mimetype="image"/></inline-formula>
</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">
<xref rid="pone.0028608-Williams1" ref-type="bibr">[30]</xref>, <xref rid="pone.0028608-Nagelkerke1" ref-type="bibr">[37]</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Heterogeneity factor <inline-formula><inline-graphic xlink:href="pone.0028608.e026.jpg" mimetype="image"/></inline-formula>
</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">Unpublished fit, <italic>see text</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Average time spent in infectious class</td><td align="left" rowspan="1" colspan="1">10 yrs</td><td align="left" rowspan="1" colspan="1">
<xref rid="pone.0028608-Todd1" ref-type="bibr">[40]</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Direct protection for circumcised males</td><td align="left" rowspan="1" colspan="1">60&#x00025;</td><td align="left" rowspan="1" colspan="1">
<xref rid="pone.0028608-Auvert1" ref-type="bibr">[8]</xref>&#x02013;<xref rid="pone.0028608-Gray1" ref-type="bibr">[10]</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Relative transmission rate <inline-formula><inline-graphic xlink:href="pone.0028608.e027.jpg" mimetype="image"/></inline-formula>
</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">
<xref rid="pone.0028608-Nicolosi1" ref-type="bibr">[32]</xref>, <xref rid="pone.0028608-Powers1" ref-type="bibr">[34]</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Behavioral disinhibition factor</td><td align="left" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1">Assumption<xref ref-type="table-fn" rid="nt101">&#x0002a;</xref>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>&#x0002a;Assumptions chosen for illustrative purposes in dynamical simulations.</p></fn></table-wrap-foot></table-wrap><p>Estimates of the difference in transmission direction (i.e. male-to-female versus female-to-male) suggest males are very roughly twice as likely to transmit HIV to female partners as females are to males, but these estimates cover a broad range <xref rid="pone.0028608-Nicolosi1" ref-type="bibr">[32]</xref>&#x02013;<xref rid="pone.0028608-Powers1" ref-type="bibr">[34]</xref>. The results shown here assume a 2&#x02236;1 ratio; results with a 1&#x02236;1 ratio are qualitatively similar.</p><p>Transmission to males in our model is reduced a further 60&#x00025; if the male is circumcised <xref rid="pone.0028608-Auvert1" ref-type="bibr">[8]</xref>&#x02013;<xref rid="pone.0028608-Gray1" ref-type="bibr">[10]</xref>. We assume that females receive no direct protection from circumcision of male partners <xref rid="pone.0028608-Wawer1" ref-type="bibr">[20]</xref>, <xref rid="pone.0028608-Weiss1" ref-type="bibr">[21]</xref>. We do not consider the short-term effect of interruption of sexual activity due to the circumcision procedure.</p><p>Baseline simulations qualitatively match observed patterns for southern African countries (see <xref rid="pone.0028608-Granich1" ref-type="bibr">[29]</xref>). In the intervention scenarios,the rate <inline-formula><inline-graphic xlink:href="pone.0028608.e028.jpg" mimetype="image"/></inline-formula> at which individuals are circumcised increases in the year 2010 (<xref ref-type="fig" rid="pone-0028608-g001">Figure 1</xref>). We increase <inline-formula><inline-graphic xlink:href="pone.0028608.e029.jpg" mimetype="image"/></inline-formula> to a level which leads the prevalence of MC to increase gradually from 15&#x00025; to 80&#x00025;. In disinhibition scenarios, the total contact rate (representing risk behaviors) increases either for all circumcised men, or only for men who were HIV- when circumcised (see <xref ref-type="sec" rid="s4">Discussion</xref>).</p></sec><sec id="s2c"><title>Parameters</title><p>It is worth noting that our equilibrium curves (<xref ref-type="fig" rid="pone-0028608-g002">Figure 2</xref>) depend on only one parameter: the heterogeneity response <inline-formula><inline-graphic xlink:href="pone.0028608.e030.jpg" mimetype="image"/></inline-formula>. Interpretation of their meaning depends additionally on five other parameters: the transmission factors <inline-formula><inline-graphic xlink:href="pone.0028608.e031.jpg" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pone.0028608.e032.jpg" mimetype="image"/></inline-formula>, the direct protection afforded to each gender by circumcision (here we assume females are not<italic>directly</italic> protected), and an assumption about disinhibition.</p><fig id="pone-0028608-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0028608.g002</object-id><label>Figure 2</label><caption><title>Expected population-level equilibrium prevalence as a function of individual-level &#x0201c;transmission factors&#x0201d;.</title><p>Contours for women's (men's) prevalence are shown in red (blue). The shapes show the pre-intervention equilibrium (solid circle), and possible long-term effects of an intervention which results in direct protection for men without (square) and with (triangle) an increase in risky behavior due to disinhibition. The heterogeneity parameter is <inline-formula><inline-graphic xlink:href="pone.0028608.e033.jpg" mimetype="image"/></inline-formula>. The shaded area shows the region in which equilibrium prevalence in women increases while that in men decreases.Other combinations of parameters, and parameter changes,, and parameter changes, can be evaluated in a similar fashion, by comparison with the red and blue lines.</p></caption><graphic xlink:href="pone.0028608.g002"/></fig><p>A list of parameters for the simulation model is given in <xref ref-type="table" rid="pone-0028608-t001">Table 1</xref>. Model parameters are derived from literature and public data, and are consistent with those used in similar models based in SSA <xref rid="pone.0028608-Alsallaq1" ref-type="bibr">[26]</xref>, <xref rid="pone.0028608-Hallett1" ref-type="bibr">[27]</xref>, <xref rid="pone.0028608-Williams1" ref-type="bibr">[30]</xref>, <xref rid="pone.0028608-Podder1" ref-type="bibr">[31]</xref>, <xref rid="pone.0028608-Londish1" ref-type="bibr">[35]</xref>. The simulation model is intended primarily to validate (and illustrate) the broader conclusions of the equilibrium model.</p></sec><sec id="s2d"><title>Code</title><p>All calculations were made using the free, open-source statistical package R <xref rid="pone.0028608-R1" ref-type="bibr">[36]</xref>. Code for all calculations, and for producing all of the figures, is available at <ext-link ext-link-type="uri" xlink:href="http://lalashan.mcmaster.ca/hivcirc/and">http://lalashan.mcmaster.ca/hivcirc/and</ext-link> can be used freely for non-commercial purposes.</p></sec></sec><sec id="s3"><title>Results</title><p>The results of the equilibrium model are shown in <xref ref-type="fig" rid="pone-0028608-g002">Figure 2</xref>. This simple model predicts long-term equilibrium prevalence as a function only of the transmission functions and the heterogeneity parameter. Thus, disinhibition due to increased contact rate or reduced condom use is modeled by proportionally increasing both transmission factors, while protection of men by circumcision is reduced by decreasing transmission from females.</p><p>The red (blue) contours show expected equilibrium prevalence in women (men) as a function of the level of effective transmission <italic>by</italic> each gender. In other words, the figure shows long-term risk to each gender (measured as equilibrium prevalence) as a function of short-term risk factors (reflected in the transmission factors). Thus, for example, as we move to the right (corresponding to increased transmission by women to men), we move &#x0201c;up&#x0201d; (away from the origin) relative to both the blue and red contours. However, we pass rapidly through blue contours (indicating rapidly increasing long-term risk to men), but more slowly through red contours (indicating less rapidly increasing long-term risk to women).</p><p>This picture allows us to visually evaluate the extent to which long-term risk to women and long-term risk to men are linked in a simple heterosexual transmission model. Starting from any contour intersection, we can ask how much latitude there is for parameter changes that have a positive effect on one gender but a negative effect on the other. If the effects of change on the two genders were closely linked, the red curves and blue curves would be nearly parallel, and there would be very little room to move in a way that is good for one gender but bad for another. Here, however, the curves are not closely matched &#x02013; a change that increases transmission by men while decreasing transmission by women (at the individual level) is likely to reduce long-term risk to men and increase long-term risk to women, despite the fact that the two genders are linked by heterosexual transmission.</p><p>As an example, the closed circle illustrates plausible parameters for a southern African country (and the long-term expected proportion ofthe sexually active population in each gender affected by HIV if these parameters don't change). The square shows how these values would change under a hypothetical circumcision intervention that directly reduces transmission to men (as a group) by 40&#x00025;, corresponding loosely to increasing circumcision from 15&#x00025; to 80&#x00025; of the population, with a 60&#x00025; protective effect for circumcised individuals. The open circle shows the effect of additionally increasing risky behavior in the whole population by 25&#x00025; (corresponding to an assumed larger increase for interactions involving circumcised men). In this example, as for many other examples with similar parameters, the effect of circumcision alone is good for both genders in the long run, while the effect of circumcision with disinhibition is good for men but bad for women.</p><p>
<xref ref-type="fig" rid="pone-0028608-g003">Figure 3</xref> shows simulation results for HIV prevalence in men and women for a hypothetical population. Baseline curves approximate the rate of growth in the early epidemic and peak in the mid 1990's, as observed in some high-prevalence sub-Saharan African countries. The baseline scenario is modified in 2010, when the rate of circumcision is scaled up to a level that eventually achieves 80&#x00025; equilibrium coverage, providing direct protection for men (60&#x00025; protective effect).</p><fig id="pone-0028608-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0028608.g003</object-id><label>Figure 3</label><caption><title>HIV prevalence response to a circumcision intervention.</title><p>Curves show prevalence through time in females (red) and males (blue) in a hypothetical population with (dashed lines) and without (solid lines) the introduction of circumcision in year 2010. We assume that circumcision does not change behavior.</p></caption><graphic xlink:href="pone.0028608.g003"/></fig><p>
<xref ref-type="fig" rid="pone-0028608-g004">Figure 4</xref> shows the same population, but with a 50&#x00025; increase in effective transmission for interactions involving circumcised males (dashed line). Here, males as a group continue to benefit from the intervention, but female prevalence increases, relative to baseline. The dotted line shows the same simulation under the assumption that increased risk behavior does not occur in men who are HIV&#x0002b; before circumcision (this could happen if they are tested and counselled at the time of circumcision, or if they do not get circumcised). In the short-term, avoiding disinhibition among such men greatly ameliorates negative effects on women (the dotted line diverges before the intervention, because we assume men who are circumcised for any reason behave differently in these scenarios). In the longer term, the two scenarios become similar, since fewer and fewer men will be infected before circumcision after many years of an active campaign.</p><fig id="pone-0028608-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0028608.g004</object-id><label>Figure 4</label><caption><title>HIV prevalence response to a circumcision intervention with behavioral disinhibition.</title><p>Curves show prevalence through time in females (red) and males (blue) in a hypothetical population with (dashed lines) and without (solid lines) the introduction of circumcision in year 2010. We assume that behavioral disinhibition leads to a 50&#x00025; increase in effective transmission for interactions involving circumcised males. Dotted lines show the case where disinhibition does not occur among individuals who were HIV-positive at the time of circumcision (see text).</p></caption><graphic xlink:href="pone.0028608.g004"/></fig></sec><sec id="s4"><title>Discussion</title><p>We have used a simple, robust equilibrium model to show that even in a population where HIV transmission is predominantly heterosexual, the link between effects on male prevalence and effects on female prevalence is only moderately strong. Simple simulations confirm these results, and underline the possibility that interventions that benefit one gender (on average) may prove harmful to the other in some cases.</p><p>The key to this somewhat counter-intuitive scenario is the possibility that, in the presence of behavioral disinhibition, fewer infectious men could infect a large number of women, who are not directly protected by circumcision. Despite the risk posed by both increased risky behavior and increased prevalence in women, however, the prevalence in men could still remain low because of the large protective effect of circumcision.</p><p>Even if the net effect of MC is to reduce overall prevalence, an increase in prevalence among females would be of concern. The gender ratio of HIV cases itself has an effect on how disease is perceived. In a region like SSA, where women have a higher HIV prevalence rate and face unique barriers to prevention, treatment, and social support following HIV/AIDS diagnosis partly because of gender inequity <xref rid="pone.0028608-Jewkes1" ref-type="bibr">[23]</xref>, MC campaigns must incorporate a gendered perspective.</p><p>Behavioral disinhibition is a common response to effective interventions. The success of MC in the long term will depend on the ability of public-health workers to control <italic>messages</italic> &#x02013; for example, whether people believe that they need to practice safe sex after circumcision, or that circumcised men are always HIV-negative. MC is irreversible and may have long-term impacts on behaviors; it is crucial that MC campaigns are careful about the messages that they communicate.</p><p>Our simulation results suggest potential negative consequences of circumcising HIV-positive men (given the subsequent disinhibition of these men or their partners), with disproportionate costs to women. On the other hand, there are potential drawbacks to attempting to exclude HIV-positive men from circumcision programs, including confidentiality, the possibility of stigma, and the possibility that such men would receive medical benefits (e.g., reduction in other STIs) from such a procedure.</p><p>Our simulation results show a relatively small overall effect of circumcision rollout. This is a direct result of our incorporation of strong, individual-level heterogeneity. Our approach to both modeling population heterogeneity and estimating its magnitude is crude, and more detailed methods <xref rid="pone.0028608-Alsallaq1" ref-type="bibr">[26]</xref>, <xref rid="pone.0028608-Nagelkerke1" ref-type="bibr">[37]</xref> may provide better estimates of population-level outcomes. We believe that the effects of heterogeneity are substantial, but our main qualitative finding &#x02013; that male and female outcomes are not tightly linked &#x02013; is not at all sensitive to our heterogeneity assumptions, or indeed to the presence of heterogeneity.</p><p>The possibility that behavioral disinhibition may accompany male circumcision does not argue against the introduction of an intervention that has the potential to reduce HIV transmission. Our results do, however, underline the need for a better understanding of the behavior implications of MC campaign and for an explicitly gendered perspective during clinical trials, intervention planning and program evaluation.</p></sec></body><back><ack><p>The authors thank Marek Smieja for advice, guidance and useful comments, and Ben Bolker, Michael Delorme, David Earn, David Fisman, Xingpeng Jiang, Mark Loeb and Lee Worden for useful comments and suggestions. J. D. thanks Simon Levin, Susan Fitzpatrick and the members of the McDonnell Social Norms group for inspiration.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This research was supported by the James S. McDonnell Foundation and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group><ref-list><title>References</title><ref id="pone.0028608-Joint1"><label>1</label><element-citation publication-type="book">
<collab>Joint United Nations Programme on HIV/AIDS</collab>
<year>2010</year>
<source>UNAIDS Report on the Global AIDS Epidemic 2010</source>
<publisher-loc>Geneva</publisher-loc>
<publisher-name>UNAIDS</publisher-name>
</element-citation></ref><ref id="pone.0028608-Grant1"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grant</surname><given-names>RM</given-names></name><name><surname>Lama</surname><given-names>JR</given-names></name><name><surname>Anderson</surname><given-names>PL</given-names></name><name><surname>McMahan</surname><given-names>V</given-names></name><name><surname>Liu</surname><given-names>AY</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.</article-title>
<source>N Engl J Med</source>
<volume>363</volume>
<fpage>2587</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="pmid">21091279</pub-id></element-citation></ref><ref id="pone.0028608-Kort1"><label>3</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kort</surname><given-names>R</given-names></name></person-group>
<year>2010</year>
<article-title>5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice - operations research.</article-title>
<source>J Int AIDS Soc</source>
<volume>13</volume>
<issue>Suppl 1</issue>
<fpage>S5</fpage>
</element-citation></ref><ref id="pone.0028608-Padian1"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Padian</surname><given-names>NS</given-names></name><name><surname>McCoy</surname><given-names>SI</given-names></name><name><surname>Karim</surname><given-names>SS</given-names></name><name><surname>Hasen</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>HIV prevention transformed: the new prevention research agenda.</article-title>
<source>Lancet</source>
<volume>378</volume>
<fpage>269</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="pmid">21763938</pub-id></element-citation></ref><ref id="pone.0028608-Cohen1"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cohen</surname><given-names>MS</given-names></name><name><surname>Chen</surname><given-names>YQ</given-names></name><name><surname>McCauley</surname><given-names>M</given-names></name><name><surname>Gamble</surname><given-names>T</given-names></name><name><surname>Hosseinipour</surname><given-names>MC</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Prevention of HIV-1 infection with early antiretroviral therapy.</article-title>
<source>N Engl J Med</source>
<volume>365</volume>
<fpage>493</fpage>
<lpage>505</lpage>
<pub-id pub-id-type="pmid">21767103</pub-id></element-citation></ref><ref id="pone.0028608-Siegfried1"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Siegfried</surname><given-names>N</given-names></name><name><surname>Muller</surname><given-names>M</given-names></name><name><surname>Deeks</surname><given-names>JJ</given-names></name><name><surname>Volmink</surname><given-names>J</given-names></name></person-group>
<year>2009</year>
<article-title>Male circumcision for prevention of heterosexual acquisition of HIV in men.</article-title>
<source>Cochrane Database Syst Rev</source>
<fpage>CD003362</fpage>
<pub-id pub-id-type="pmid">19370585</pub-id></element-citation></ref><ref id="pone.0028608-World1"><label>7</label><element-citation publication-type="book">
<collab>World Health Organization</collab>
<year>2007</year>
<source>New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications</source>
<publisher-loc>Geneva</publisher-loc>
<publisher-name>World Health Organization</publisher-name>
</element-citation></ref><ref id="pone.0028608-Auvert1"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Auvert</surname><given-names>B</given-names></name><name><surname>Taljaard</surname><given-names>D</given-names></name><name><surname>Lagarde</surname><given-names>E</given-names></name><name><surname>Tambekou</surname><given-names>J</given-names></name><name><surname>Sitta</surname><given-names>R</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.</article-title>
<source>PLoS Med</source>
<volume>2</volume>
<fpage>e298</fpage>
<pub-id pub-id-type="pmid">16231970</pub-id></element-citation></ref><ref id="pone.0028608-Bailey1"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bailey</surname><given-names>RC</given-names></name><name><surname>Moses</surname><given-names>S</given-names></name><name><surname>Parker</surname><given-names>CB</given-names></name><name><surname>Agot</surname><given-names>K</given-names></name><name><surname>Maclean</surname><given-names>I</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.</article-title>
<source>Lancet</source>
<volume>369</volume>
<fpage>643</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">17321310</pub-id></element-citation></ref><ref id="pone.0028608-Gray1"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gray</surname><given-names>RH</given-names></name><name><surname>Kigozi</surname><given-names>G</given-names></name><name><surname>Serwadda</surname><given-names>D</given-names></name><name><surname>Makumbi</surname><given-names>F</given-names></name><name><surname>Watya</surname><given-names>S</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.</article-title>
<source>Lancet</source>
<volume>369</volume>
<fpage>657</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="pmid">17321311</pub-id></element-citation></ref><ref id="pone.0028608-Kalichman1"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kalichman</surname><given-names>S</given-names></name><name><surname>Eaton</surname><given-names>L</given-names></name><name><surname>Pinkerton</surname><given-names>S</given-names></name></person-group>
<year>2007</year>
<article-title>Circumcision for HIV prevention: failure to fully account for behavioral risk compensation.</article-title>
<source>PLoS Med</source>
<volume>4</volume>
<fpage>e138</fpage>
<lpage>author reply e146</lpage>
<pub-id pub-id-type="pmid">17388676</pub-id></element-citation></ref><ref id="pone.0028608-Cassell1"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cassell</surname><given-names>MM</given-names></name><name><surname>Halperin</surname><given-names>DT</given-names></name><name><surname>Shelton</surname><given-names>JD</given-names></name><name><surname>Stanton</surname><given-names>D</given-names></name></person-group>
<year>2006</year>
<article-title>Risk compensation: the Achilles' heel of innovations in HIV prevention?</article-title>
<source>BMJ</source>
<volume>332</volume>
<fpage>605</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">16528088</pub-id></element-citation></ref><ref id="pone.0028608-Jackson1"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jackson</surname><given-names>DJ</given-names></name><name><surname>Martin</surname><given-names>HL</given-names></name><name><surname>Bwayo</surname><given-names>JJ</given-names></name><name><surname>Nyange</surname><given-names>PM</given-names></name><name><surname>Rakwar</surname><given-names>JP</given-names></name><etal/></person-group>
<year>1995</year>
<article-title>Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya.</article-title>
<source>AIDS</source>
<volume>9</volume>
<fpage>1279</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmid">8561982</pub-id></element-citation></ref><ref id="pone.0028608-Crepaz1"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Crepaz</surname><given-names>N</given-names></name><name><surname>Hart</surname><given-names>TA</given-names></name><name><surname>Marks</surname><given-names>G</given-names></name></person-group>
<year>2004</year>
<article-title>Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review.</article-title>
<source>JAMA</source>
<volume>292</volume>
<fpage>224</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="pmid">15249572</pub-id></element-citation></ref><ref id="pone.0028608-Sherr1"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sherr</surname><given-names>L</given-names></name><name><surname>Lopman</surname><given-names>B</given-names></name><name><surname>Kakowa</surname><given-names>M</given-names></name><name><surname>Dube</surname><given-names>S</given-names></name><name><surname>Chawira</surname><given-names>G</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Voluntary counselling and testing: uptake, impact on sexual behaviour, and HIV incidence in a rural Zimbabwean cohort.</article-title>
<source>AIDS</source>
<volume>21</volume>
<fpage>851</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="pmid">17415040</pub-id></element-citation></ref><ref id="pone.0028608-Vinod1"><label>16</label><element-citation publication-type="book">
<collab>Vinod Mishra, and Simona Bignami-Van Assche</collab>
<year>2009</year>
<source>Concurrent sexual partnership and HIV infection: Evidence from national population-based surveys. DHS working paper, no. 62</source>
<publisher-loc>Calverton, , Maryland</publisher-loc>
<publisher-name>Marco International Press</publisher-name>
</element-citation></ref><ref id="pone.0028608-Agot1"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Agot</surname><given-names>KE</given-names></name><name><surname>Kiarie</surname><given-names>JN</given-names></name><name><surname>Nguyen</surname><given-names>HQ</given-names></name><name><surname>Odhiambo</surname><given-names>JO</given-names></name><name><surname>Onyango</surname><given-names>TM</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Male cir- cumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision.</article-title>
<source>J Acquir Immune Defic Syndr</source>
<volume>44</volume>
<fpage>66</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">17019365</pub-id></element-citation></ref><ref id="pone.0028608-Matovu1"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matovu</surname><given-names>JK</given-names></name><name><surname>Ssempijja</surname><given-names>V</given-names></name><name><surname>Makumbi</surname><given-names>FE</given-names></name><name><surname>Gray</surname><given-names>RH</given-names></name><name><surname>Kigozi</surname><given-names>G</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Sexually transmitted infection management, safer sex promotion and voluntary HIV counselling and testing in the male circumcision trial, Rakai, Uganda.</article-title>
<source>Reprod Health Matters</source>
<volume>15</volume>
<fpage>68</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">17512378</pub-id></element-citation></ref><ref id="pone.0028608-Andersson1"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andersson</surname><given-names>N</given-names></name><name><surname>Cockcroft</surname><given-names>A</given-names></name></person-group>
<year>2011</year>
<article-title>Male circumcision, attitudes to HIV prevention and HIV status: a cross-sectional study in Botswana, Namibia and Swaziland.</article-title>
<source>AIDS Care</source>
</element-citation></ref><ref id="pone.0028608-Wawer1"><label>20</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wawer</surname><given-names>MJ</given-names></name><name><surname>Makumbi</surname><given-names>F</given-names></name><name><surname>Kigozi</surname><given-names>G</given-names></name><name><surname>Serwadda</surname><given-names>D</given-names></name><name><surname>Watya</surname><given-names>S</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Circumcision in HIV- infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial.</article-title>
<source>Lancet</source>
<volume>374</volume>
<fpage>229</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="pmid">19616720</pub-id></element-citation></ref><ref id="pone.0028608-Weiss1"><label>21</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weiss</surname><given-names>HA</given-names></name><name><surname>Hankins</surname><given-names>CA</given-names></name><name><surname>Dickson</surname><given-names>K</given-names></name></person-group>
<year>2009</year>
<article-title>Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis.</article-title>
<source>Lancet Infect Dis</source>
<volume>9</volume>
<fpage>669</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="pmid">19850225</pub-id></element-citation></ref><ref id="pone.0028608-Joint2"><label>22</label><element-citation publication-type="book">
<collab>Joint United Nations Programme on HIV/AIDS</collab>
<year>2008</year>
<source>Report on global AIDS epidemic complete report</source>
<publisher-loc>Geneva</publisher-loc>
<publisher-name>UNAIDS</publisher-name>
</element-citation></ref><ref id="pone.0028608-Jewkes1"><label>23</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jewkes</surname><given-names>R</given-names></name></person-group>
<year>2010</year>
<article-title>HIV/AIDS. Gender inequities must be addressed in HIV prevention.</article-title>
<source>Science</source>
<volume>329</volume>
<fpage>145</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">20616253</pub-id></element-citation></ref><ref id="pone.0028608-Andersson2"><label>24</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andersson</surname><given-names>N</given-names></name><name><surname>Foster</surname><given-names>A</given-names></name><name><surname>Mitchell</surname><given-names>S</given-names></name><name><surname>Scheepers</surname><given-names>E</given-names></name><name><surname>Goldstein</surname><given-names>S</given-names></name></person-group>
<year>2007</year>
<article-title>Risk factors for domestic physical violence: national cross-sectional household surveys in eight southern African countries.</article-title>
<source>BMC Womens Health</source>
<volume>7</volume>
<fpage>11</fpage>
<pub-id pub-id-type="pmid">17631689</pub-id></element-citation></ref><ref id="pone.0028608-Group1"><label>25</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Group</surname><given-names>UE</given-names></name></person-group>
<year>2009 Sep</year>
<article-title>Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?</article-title>
<source>PLoS Med</source>
<volume>6</volume>
<fpage>e1000109</fpage>
<pub-id pub-id-type="pmid">19901974</pub-id></element-citation></ref><ref id="pone.0028608-Alsallaq1"><label>26</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alsallaq</surname><given-names>RA</given-names></name><name><surname>Cash</surname><given-names>B</given-names></name><name><surname>Weiss</surname><given-names>HA</given-names></name><name><surname>IML</surname><suffix>Jr</suffix></name><name><surname>Omer</surname><given-names>SB</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Quantitative assessment of the role of male circumcision in HIV epidemiology at the population level.</article-title>
<source>Epidemics</source>
<volume>1</volume>
<fpage>139</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="pmid">21352761</pub-id></element-citation></ref><ref id="pone.0028608-Hallett1"><label>27</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hallett</surname><given-names>TB</given-names></name><name><surname>Singh</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>JA</given-names></name><name><surname>White</surname><given-names>RG</given-names></name><name><surname>Raddad</surname><given-names>LJ</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa.</article-title>
<source>PLoS One</source>
<volume>3</volume>
<fpage>e2212</fpage>
<pub-id pub-id-type="pmid">18493593</pub-id></element-citation></ref><ref id="pone.0028608-Bailey2"><label>28</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Bailey</surname></name><name><surname>NTJ</surname></name></person-group>
<year>1982</year>
<source>The Biomathematics of Malaria</source>
<publisher-loc>London and High Wycombe</publisher-loc>
<publisher-name>Charles Griffin and Co. Ltd.</publisher-name>
</element-citation></ref><ref id="pone.0028608-Granich1"><label>29</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Granich</surname><given-names>RM</given-names></name><name><surname>Gilks</surname><given-names>CF</given-names></name><name><surname>Dye</surname><given-names>C</given-names></name><name><surname>De</surname><given-names>C</given-names></name><name><surname>Williams</surname><given-names>BG</given-names></name></person-group>
<year>2009</year>
<article-title>Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.</article-title>
<source>Lancet</source>
<volume>373</volume>
<fpage>48</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="pmid">19038438</pub-id></element-citation></ref><ref id="pone.0028608-Williams1"><label>30</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Williams</surname><given-names>BG</given-names></name><name><surname>Smith</surname><given-names>JO</given-names></name><name><surname>Gouws</surname><given-names>E</given-names></name><name><surname>Hankins</surname><given-names>C</given-names></name><name><surname>Getz</surname><given-names>WM</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>The potential impact of male circumcision on HIV in Sub-Saharan Africa.</article-title>
<source>PLoS Med</source>
<volume>3</volume>
<fpage>e262</fpage>
<pub-id pub-id-type="pmid">16822094</pub-id></element-citation></ref><ref id="pone.0028608-Podder1"><label>31</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Podder</surname><given-names>CN</given-names></name><name><surname>Sharomi</surname><given-names>O</given-names></name><name><surname>Gumel</surname><given-names>AB</given-names></name><name><surname>Moses</surname><given-names>S</given-names></name></person-group>
<year>2007</year>
<article-title>To cut or not to cut: a modeling approach for assessing the role of male circumcision in HIV control.</article-title>
<source>Bull Math Biol</source>
<volume>69</volume>
<fpage>2447</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="pmid">17557187</pub-id></element-citation></ref><ref id="pone.0028608-Nicolosi1"><label>32</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nicolosi</surname><given-names>A</given-names></name><name><surname>Correa</surname><given-names>L</given-names></name><name><surname>Musicco</surname><given-names>M</given-names></name><name><surname>Arici</surname><given-names>C</given-names></name><name><surname>Gavazzeni</surname><given-names>G</given-names></name><etal/></person-group>
<year>1994</year>
<article-title>The efficiency of male- to-female and female-to-male sexual transmission of the human immunodefficiency virus: a study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission.</article-title>
<source>Epidemiology</source>
<volume>5</volume>
<fpage>570</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">7841237</pub-id></element-citation></ref><ref id="pone.0028608-Melo1"><label>33</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Melo</surname><given-names>MG</given-names></name><name><surname>Santos</surname><given-names>BR</given-names></name><name><surname>De</surname><given-names>C</given-names></name><name><surname>Varella</surname><given-names>IS</given-names></name><name><surname>Turella</surname><given-names>ML</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Sexual transmission of HIV-1 among serodiscordant couples in Porto Alegre, southern Brazil.</article-title>
<source>Sex Transm Dis</source>
<volume>35</volume>
<fpage>912</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">18607309</pub-id></element-citation></ref><ref id="pone.0028608-Powers1"><label>34</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Powers</surname><given-names>KA</given-names></name><name><surname>Poole</surname><given-names>C</given-names></name><name><surname>Pettifor</surname><given-names>AE</given-names></name><name><surname>Cohen</surname><given-names>MS</given-names></name></person-group>
<year>2008</year>
<article-title>Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis.</article-title>
<source>Lancet Infect Dis</source>
<volume>8</volume>
<fpage>553</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">18684670</pub-id></element-citation></ref><ref id="pone.0028608-Londish1"><label>35</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Londish</surname><given-names>GJ</given-names></name><name><surname>Murray</surname><given-names>JM</given-names></name></person-group>
<year>2008</year>
<article-title>Significant reduction in HIV prevalence according to male circumcision intervention in sub-Saharan Africa.</article-title>
<source>Int J Epidemiol</source>
<volume>37</volume>
<fpage>1246</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="pmid">18316348</pub-id></element-citation></ref><ref id="pone.0028608-R1"><label>36</label><element-citation publication-type="other">
<article-title>R Development Core Team (downloaded 2008&#x02013;2010).</article-title>
<comment>R project for statistical computing. <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link></comment>
</element-citation></ref><ref id="pone.0028608-Nagelkerke1"><label>37</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagelkerke</surname><given-names>NJ</given-names></name><name><surname>Moses</surname><given-names>S</given-names></name><name><surname>de</surname><given-names>V</given-names></name><name><surname>Bailey</surname><given-names>RC</given-names></name></person-group>
<year>2007</year>
<article-title>Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.</article-title>
<source>BMC Infect Dis</source>
<volume>7</volume>
<fpage>16</fpage>
<pub-id pub-id-type="pmid">17355625</pub-id></element-citation></ref><ref id="pone.0028608-Joint3"><label>38</label><element-citation publication-type="book">
<collab>Joint United Nations Programme on HIV/AIDS</collab>
<year>2009</year>
<source>Country experiences in the scale-up of male circumcision in the Eastern and Southern Africa Region: Two years and counting</source>
<publisher-loc>Geneva</publisher-loc>
<publisher-name>UNAIDS</publisher-name>
</element-citation></ref><ref id="pone.0028608-World2"><label>39</label><element-citation publication-type="book">
<collab>World Health Organization</collab>
<year>2009</year>
<source>World Health Statistics 2009: Mortality and burden of disease</source>
<publisher-loc>Geneva</publisher-loc>
<publisher-name>World Health Organization</publisher-name>
</element-citation></ref><ref id="pone.0028608-Todd1"><label>40</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Todd</surname><given-names>J</given-names></name><name><surname>Glynn</surname><given-names>JR</given-names></name><name><surname>Marston</surname><given-names>M</given-names></name><name><surname>Lutalo</surname><given-names>T</given-names></name><name><surname>Biraro</surname><given-names>S</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy.</article-title>
<source>AIDS</source>
<volume>21</volume>
<issue>Suppl 6</issue>
<fpage>S55</fpage>
<lpage>63</lpage>
</element-citation></ref></ref-list></back></article>